Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology), M.R.C.P-I (UK)
Cardiologist
M.B.B.S., F.C.P.S., MRCP
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Gastroenterologist
MBBS, MACG (USA), MD (Gastroenterology)
Gastroenterologist
MBBS, FCPS (Medicine) ,DCPS (Gastro), MRCS (Gastro), M.D
Gastroenterologist
MBBS, FCPS (Medicine) ,DCPS (Gastro), MRCS (Gastro), M.D
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures